BioNexus Gene Lab Corp. (简称BGLC) 已正式完成对Chemrex的治理架构重组工作。此次重组标志着公司在优化管理体系方面迈出关键一步。与此同时,BioNexus Gene Lab Corp. 宣布任命Matthew Barsing担任董事会主席一职,这一人事变动有望为公司的战略发展注入新的领导力。
BioNexus Gene Lab Corp. (简称BGLC) 已正式完成对Chemrex的治理架构重组工作。此次重组标志着公司在优化管理体系方面迈出关键一步。与此同时,BioNexus Gene Lab Corp. 宣布任命Matthew Barsing担任董事会主席一职,这一人事变动有望为公司的战略发展注入新的领导力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.